Genetic-epidemiological evidence for the role of acetaldehyde in cancers related to alcohol drinking.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing genetic-epidemiological literature without systematic review or meta-analysis protocol
PubMed 25427900 · doi:10.1007/978-3-319-09614-8_3
What was done
This survey evaluated the carcinogenic role of acetaldehyde in alcohol-related malignancies, focusing on genetic-epidemiological data. The review examined the mechanistic role of acetaldehyde derived from beverage content, microbial oxidation, and endogenous metabolism, alongside epidemiological evidence involving the aldehyde dehydrogenase 2 (*ALDH2*, rs671*2) polymorphism.
What was found
The abstract reports no numerical risk estimates or effect sizes. It notes that the International Agency for Research on Cancer (IARC) categorized alcohol-related acetaldehyde as a Group 1 carcinogen for head, neck, and esophageal cancers. Recent studies reviewed also demonstrated positive associations between the inactive *ALDH2* rs671*2 allele and gastric, colorectal, lung, and hepatocellular cancers.
Why it matters
It reinforces acetaldehyde as a key causal mediator in alcohol-induced carcinogenesis across the digestive tract. Phenotypic markers of *ALDH2* deficiency, such as flushing and nausea, represent practical tools for targeted cancer prevention and public health education.
Limits
The abstract provides no quantitative data, search methodology, or study counts. The author notes that many underlying case-control studies fail to properly match or stratify for alcohol consumption levels, creating potential confounding and misleading interpretations in the primary literature.
Cited by
- supports Ethanol is classified as a Group 1 carcinogen by the International Agency for Research on Cancer (IARC).